0 Σχόλια
0 Μοιράστηκε
206 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Σχόλια 0 Μοιράστηκε 516 Views 0 Προεπισκόπηση
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Σχόλια 0 Μοιράστηκε 141 Views 0 Προεπισκόπηση
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Σχόλια 0 Μοιράστηκε 618 Views 0 Προεπισκόπηση
-
Global Oncology Small Molecule Drugs Market by 2031: Competitive Landscape and North America InsightsThe global oncology small molecule drugs market is experiencing steady expansion, driven by the rising global burden of cancer, increasing adoption of targeted therapies, and continuous advancements in drug discovery technologies. These drugs play a crucial role in cancer treatment by interfering with specific molecular pathways involved in tumor growth and progression. According to market...0 Σχόλια 0 Μοιράστηκε 137 Views 0 Προεπισκόπηση
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Σχόλια 0 Μοιράστηκε 142 Views 0 Προεπισκόπηση
-
Is Synthetic Lethality the Future Breakthrough in Targeted Cancer Therapy?Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market research report guides the...0 Σχόλια 0 Μοιράστηκε 384 Views 0 Προεπισκόπηση
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)